Furthermore, we observed only a weak correlation between CSF pleiocytosis or CSF IgG index and transformation efficiency, indicating that factors other than a higher number/proportion of CSF B cells in the MS cohort must underlie the differences in transformation efficiency. This evidence concerns the gene CSF2 and myeloid sarcoma.